• Login
    View Item 
    •   Home
    • 1 Published Research and Commentary
    • Health Politics
    • View Item
    •   Home
    • 1 Published Research and Commentary
    • Health Politics
    • View Item
    Mar 04, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CollectionTitleAuthorsSubjectsPublisherJournal

    Drug development for neglected diseases: a deficient market and a public-health policy failure.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Access Trouiller 2002.pdf
    Size:
    106.4Kb
    Format:
    PDF
    Download
    Authors
    Trouiller, P
    Olliaro, P
    Torreele, E
    Orbinski, J
    Laing, R
    Ford, N
    Affiliation
    Centre Hospitalier Universitaire, BP 217, 38043 Grenoble cedex 9, France. PTrouiller@chu-grenoble.fr
    Issue Date
    2002-06-22
    
    Metadata
    Show full item record
    Journal
    Lancet
    Abstract
    There is a lack of effective, safe, and affordable pharmaceuticals to control infectious diseases that cause high mortality and morbidity among poor people in the developing world. We analysed outcomes of pharmaceutical research and development over the past 25 years, and reviewed current public and private initiatives aimed at correcting the imbalance in research and development that leaves diseases that occur predominantly in the developing world largely unaddressed. We compiled data by searches of Medline and databases of the US Food and Drug Administration and the European Agency for the Evaluation of Medicinal Products, and reviewed current public and private initiatives through an analysis of recently published studies. We found that, of 1393 new chemical entities marketed between 1975 and 1999, only 16 were for tropical diseases and tuberculosis. There is a 13-fold greater chance of a drug being brought to market for central-nervous-system disorders or cancer than for a neglected disease. The pharmaceutical industry argues that research and development is too costly and risky to invest in low-return neglected diseases, and public and private initiatives have tried to overcome this market limitation through incentive packages and public-private partnerships. The lack of drug research and development for "non-profitable" infectious diseases will require new strategies. No sustainable solution will result for diseases that predominantly affect poor people in the South without the establishment of an international pharmaceutical policy for all neglected diseases. Private-sector research obligations should be explored, and a public-sector not-for-profit research and development capacity promoted.
    Publisher
    Elsevier
    URI
    http://hdl.handle.net/10144/28441
    DOI
    10.1016/S0140-6736(02)09096-7
    PubMed ID
    12090998
    Language
    en
    ISSN
    0140-6736
    ae974a485f413a2113503eed53cd6c53
    10.1016/S0140-6736(02)09096-7
    Scopus Count
    Collections
    Health Politics

    entitlement

    Related articles

    • [Development of antituberculous drugs: current status and future prospects].
    • Authors: Tomioka H, Namba K
    • Issue date: 2006 Dec
    • Initial lessons from public-private partnerships in drug and vaccine development.
    • Authors: Wheeler C, Berkley S
    • Issue date: 2001
    • Public-private partnerships for health: their main targets, their diversity, and their future directions.
    • Authors: Widdus R
    • Issue date: 2001
    • [Status of research and development for control of tropical diseases: hypocrisy, indifference or lack of coordination].
    • Authors: Millet P
    • Issue date: 2006 Dec
    • Stimulating research and development of pharmaceutical products for neglected diseases.
    • Authors: Stirner B
    • Issue date: 2008 Dec
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.